PACSvsUnitedHealth

PACS and UNH stock compared: price, dividend, valuation and results, from SEC filings.

PACS

PACS Group, Inc.

$43.67

Value $6.9B

+1.49%
PACS's page

UNH

UnitedHealth Group Incorporated

$339.85

Value $308B

+2.84%
UNH's page

PACS (PACS) has a market value of $6.9B and UnitedHealth (UNH) $308B. Over the last year, with dividends, PACS moved +159.5% and UNH +12.9%. The P/E is 24.7 for PACS and 19.4 for UNH. Dividend yield: PACS none, UNH 2.67%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    PACS$6.9B

    UNH$308B

    UNH is 45 times PACS

  • Revenue, 12 months

    PACS$5.7B

    UNH$450B

    UNH is 79 times PACS

  • Net income, 12 months

    PACS$278M

    UNH$15.9B

    UNH is 57 times PACS

  • Operating margin

    PACS7.4%

    UNH5.3%

    2.1 points apart

  • ROIC

    PACS22.9%

    UNH11.3%

    11.6 points apart

  • P/E

    PACS24.7

    UNH19.4

    PACS is 1.3 times UNH

  • Dividend yield

    PACS0.0%

    UNH2.7%

    2.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

PACS+159.5%

UNH+12.9%

100200300DecFebAprJunAugOct
Returns by period
PeriodPACSWith dividendsUNHWith dividends
1 year since November 19, 2025+159.5%Price +159.5%+12.9%Price +10.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

PACSPACSUNHUnitedHealth

Valuation

PACSUNH
Valuation
Price$43.67$339.85
Market value$6.9B$308B
Enterprise value (EV)$7.1B$354B
P/E24.719.4
P/E, 5-year median–25.0
P/B5.73.0
EV/EBIT16.714.8
Free cash flow yield6.5%7.4%

Results and growth

PACSUNH
Results and growth
Revenue, 12 months$5.7B$450B
Net income, 12 months$278M$15.9B
Free cash flow, 12 months$448M$22.8B
Earnings per share, 12 months$1.76$17.52
Revenue growth, year on year29.4%11.8%
Revenue growth a year, past+30.1%over 3 years+11.7%over 5 years
EPS growth a year, past+1.4%over 3 years-3.8%over 5 years

Margins and returns on capital

PACSUNH
Margins and returns on capital
Gross margin23.8%88.3%
Operating margin7.4%5.3%
Net margin4.9%3.5%
ROIC22.9%11.3%
ROE26.8%15.5%

Balance sheet

PACSUNH
Balance sheet
Cash$115M$28.5B
Total debt$3.4B$74.3B
Net debt / EBITDA–1.6
Interest cover16.2×6.2×

Dividends and buybacks

PACSUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: PACS or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, PACS or UnitedHealth?

By market value, UnitedHealth ($308B) is about 44.9 times PACS ($6.9B), at today's prices.

How did PACS and UNH stock do over the last 1 years?

Since November 19, 2025, PACS's price moved +159.5% and UNH's +10.0%. With dividends: PACS +159.5% (+159.5% a year), UNH +12.9% (+12.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, PACS or UNH?

The dividend yield at today's price is none for PACS and 2.67% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

What is the P/E of PACS and UNH?

At today's price, the P/E is 24.7 for PACS and 19.4 for UNH. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, PACS or UnitedHealth?

Over the last twelve months, the net margin was 4.9% for PACS and 3.5% for UnitedHealth, and the operating margin 7.4% and 5.3%. Revenue was $5.7B and $450B.

Which is the better investment, PACS or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.